Establishment Labs (ESTA) stock price, revenue, and financials

Establishment Labs market cap is $434.9 m, and annual revenue was $89.57 m in FY 2019

$434.9 M

ESTA Mkt cap, 14-Sept-2020

$10.5 M

Establishment Labs Revenue Q2, 2020
Establishment Labs Gross profit (Q2, 2020)7.2 M
Establishment Labs Gross profit margin (Q2, 2020), %69.1%
Establishment Labs Net income (Q2, 2020)-10.5 M
Establishment Labs EBIT (Q2, 2020)-9.6 M
Establishment Labs Cash, 30-Jun-202086.4 M
Establishment Labs EV397.4 M

Establishment Labs Revenue

Establishment Labs revenue was $89.57 m in FY, 2019

Embed Graph

Establishment Labs Income Statement

Annual

USDFY, 2018FY, 2019

Revenue

61.2m89.6m

Cost of goods sold

25.1m34.7m

Gross profit

36.1m54.9m

Gross profit Margin, %

59%61%

R&D expense

12.7m15.0m

General and administrative expense

47.3m70.8m

Operating expense total

60.0m85.8m

EBIT

(23.9m)(30.9m)

EBIT margin, %

(39%)(35%)

Interest income

16.0k4.0k

Pre tax profit

(20.9m)(37.5m)

Income tax expense

215.0k640.0k

Net Income

(21.1m)(38.1m)

Quarterly

USDQ2, 2018Q3, 2018Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Revenue

13.7m16.3m21.7m22.9m24.5m10.5m

Cost of goods sold

5.5m6.2m8.7m8.6m9.0m3.2m

Gross profit

8.2m10.1m13.0m14.2m15.5m7.2m

Gross profit Margin, %

60%62%60%62%63%69%

R&D expense

3.7m3.2m4.0m3.8m4.2m2.4m

General and administrative expense

10.8m13.0m18.4m19.2m19.0m14.4m

Operating expense total

14.5m16.2m22.4m23.0m23.2m16.8m

Depreciation and amortization

200.0k200.0k

EBIT

(6.3m)(6.0m)(9.4m)(8.8m)(7.7m)(9.6m)

EBIT margin, %

(46%)(37%)(43%)(38%)(31%)(92%)

Interest income

5.0k4.0k3.0k8.0k2.0k

Pre tax profit

(5.2m)1.2m(9.0m)(12.5m)(17.5m)(10.3m)

Income tax expense

152.0k(99.0k)35.0k308.0k231.0k194.0k

Net Income

(5.4m)1.3m(9.0m)(12.8m)(17.8m)(10.5m)

Establishment Labs Balance Sheet

Annual

USDFY, 2018FY, 2019

Cash

52.6m37.7m

Accounts Receivable

17.6m22.8m

Prepaid Expenses

4.3m6.8m

Inventories

24.8m28.7m

Current Assets

99.4m95.8m

PP&E

12.9m16.4m

Goodwill

465.0k465.0k

Total Assets

116.6m116.5m

Accounts Payable

6.2m10.4m

Short-term debt

1.2m

Current Liabilities

16.4m23.2m

Long-term debt

22.3m48.1m

Total Debt

23.5m48.1m

Total Liabilities

47.1m76.9m

Common Stock

147.7m

Additional Paid-in Capital

15.2m21.2m

Retained Earnings

(89.0m)(127.1m)

Total Equity

69.5m39.6m

Debt to Equity Ratio

0.3 x

Debt to Assets Ratio

0.2 x

Financial Leverage

1.7 x2.9 x

Establishment Labs Cash Flow

Annual

USDFY, 2018FY, 2019

Net Income

(21.1m)(38.1m)

Accounts Receivable

(4.7m)(5.5m)

Inventories

(7.0m)(3.4m)

Accounts Payable

(3.9m)1.8m

Cash From Operating Activities

(33.9m)(30.0m)

Purchases of PP&E

(1.7m)(6.3m)

Cash From Investing Activities

(5.7m)(7.8m)

Long-term Borrowings

(311.0k)(242.0k)

Cash From Financing Activities

81.5m22.8m

Net Change in Cash

41.8m(15.0m)

Interest Paid

5.4m5.9m

Income Taxes Paid

136.0k649.0k

Quarterly

Establishment Labs Ratios

USDQ2, 2018

Revenue/Employee

31.3k

Debt/Equity

9.1 x

Debt/Assets

0.3 x

Financial Leverage

26.7 x

Establishment Labs Operating Metrics

FY, 2017FY, 2018

Countries

60 60

Motiva Implants Sold to Date

446 k650 k

Product Lines

3 3